Biden-Harris Administration Marks Two Years of Advancements in HHS’ Overdose Prevention Strategy with New Actions to Treat Addiction and Save Lives
Continuing to build on unprecedented action to expand access to substance use disorder treatment, the Biden-Harris Administration finalizes historic updates to decades-old federal regulations for opioid treatment programs. HHS also announces certain grant funds may be used to purchase xylazine test strips to detect dangerous substance in illicit drug supply. Today, (February 1) the U.S. Department of Health and Human Services (HHS) marked two years of its Overdose Prevention Strategy (Strategy) by announcing bold new actions to combat overdoses. These actions include finalizing a rule that will dramatically expand access to life-saving medications for opioid use disorder, announcing that certain grant funds may now be used to purchase xylazine test strips (XTS), and releasing the Substance Abuse and Mental Health Services Administration’s (SAMHSA) updated Overdose Prevention and Response Toolkit . Actions announced today build on President Biden’s National Drug Control Strategy